Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Moodys
Boehringer Ingelheim
Baxter
Harvard Business School

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 212279


Email this page to a colleague

« Back to Dashboard

NDA 212279 describes EXEM FOAM KIT, which is a drug marketed by Giskit and is included in one NDA. There are three patents protecting this drug. Additional details are available on the EXEM FOAM KIT profile page.

The generic ingredient in EXEM FOAM KIT is air polymer-type a. There are thirty-seven drug master file entries for this compound. Additional details are available on the air polymer-type a profile page.
Summary for 212279
Tradename:EXEM FOAM KIT
Applicant:Giskit
Ingredient:air polymer-type a
Patents:3
DrugPatentWatch® Estimated Generic Entry Opportunity Date for 212279
Generic Entry Date for 212279*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY
Dosage:
FOAM;INTRAUTERINE

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOAM;INTRAUTERINEStrength10ML
Approval Date:Nov 7, 2019TE:RLD:Yes
Regulatory Exclusivity Expiration:Nov 7, 2024
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:⤷  Free Forever TrialPatent Expiration:Oct 15, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE IN SONOHYSTEROSALPINOGRAPHY TO ASSESS FALLOPIAN TUBE PATENCY
Patent:⤷  Free Forever TrialPatent Expiration:May 4, 2035Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE IN SONOHYSTEROSALPINOGRAPHY TO ASSESS FALLOPIAN TUBE PATENCY

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Medtronic
McKesson
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.